Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis

BJU International

Volumn 103, Issue 8, 2009, Pages 1040-1046

  Bolenz, Christian ^a,b   Fernández, Mario I ^d   Trojan, Lutz ^b   Hoffmann, Katja ^b   Herrmann, Edwin ^b   Steidler, Annette ^b   Weiss, Christel ^b   Ströbel, Philipp ^c   Alken, Peter ^b   Michel, Maurice Stephan ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

Lymphangiogenesis; Lymphatic vessels; Metastasis; Podoplanin; Prognosis; Transitional cell carcinoma; Urinary tract cancer

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY D2-40;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROGNOSIS; UROGENITAL TRACT CANCER; UROTHELIAL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; TREATMENT OUTCOME; UROLOGIC NEOPLASMS;

EID: 63449098334     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08135.x     Document Type: Article

References (30)

1. Lotan Y, Gupta A, Shariat SF et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005 23 : 6533 9
2. Shariat SF, Karakiewicz PI, Palapattu GS et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006 176 : 2414 22
3. Novara G, De Marco V, Gottardo F et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 2007 110 : 1715 22
4. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005 438 : 946 53
5. Alitalo K, Mohla S, Ruoslahti E. Lymphangiogenesis and cancer: meeting report. Cancer Res 2004 64 : 9225 9
6. Miyata Y, Kanda S, Ohba K et al. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 2006 176 : 348 53
7. Kikuchi E, Horiguchi Y, Nakashima J. et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol 2005 174 : 2120 3
8. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004 25 : 387 95
9. Juttner S, Wissmann C, Jons T et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 2006 24 : 228 40
10. Miyata Y, Kanda S, Ohba K et al. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A-C, and -D. Clin Cancer Res 2006 12 : 800 6
11. Herrmann E, Eltze E, Bierer S et al. VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival. Anticancer Res 2007 27 : 3127 33
12. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007 8 : 464 78
13. Fernandez MI, Bolenz C, Trojan L et al. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol 2008 53 : 571 8
14. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic markerpodoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005 166 : 913 21
15. Kaiserling E. [Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology]. Pathologe 2004 25 : 362 74
16. Dadras SS, Paul T, Bertoncini J et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003 162 : 1951 60
17. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005 206 : 170 7
18. Renyi-Vamos F, Tovari J, Fillinger J et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005 11 : 7344 53
19. Zeng Y, Opeskin K, Horvath LG, Sutherland RL, Williams ED. Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 2005 65 : 222 30
20. Liang P, Hong JW, Ubukata H et al. Increased density and diameter of lymphatic microvessels correlate with lymph node metastasis in early stage invasive colorectal carcinoma. Virchows Arch 2006 448 : 570 5
21. UICC. TNM Classification of Malignant Tumours, 6th edn. New York : Wiley, 2002
22. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinarybladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 22 : 1435 48
23. Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, Grobholz R. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol 2004 172 : 103 7
24. Oosterlinck W, Solsona E, van der Meijden AP et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 2004 46 : 147 54
25. Van der Auwera I, Van den Eynden GG, Colpaert CG et al. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res 2005 11 : 7637 42
26. Cassella M, Skobe M. Lymphatic vessel activation in cancer. Ann N Y Acad Sci 2002 979 : 120 30
27. Padera TP, Kadambi A, di Tomaso E et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002 296 : 1883 6
28. Williams CS, Leek RD, Robson AM et al. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 2003 200 : 195 206
29. Agarwal B, Saxena R, Morimiya A, Mehrotra S, Badve S. Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol 2005 29 : 1449 55
30. Van der Auwera I, Cao Y, Tille JC et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006 95 : 1611 25